Company profile: Corvidia Therapeutics
1.1 - Company Overview
Company description
- Provider of clinical-stage research, development, and commercialization of transformative therapies for cardio-renal diseases, currently developing potential treatments for chronic kidney disease with atherosclerotic cardiovascular disease and inflammation.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Corvidia Therapeutics
Saranas
HQ: United States
Website
- Description: Provider of a medical device that detects internal bleeding during catheterization procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Saranas company profile →
Angiodroid
HQ: Italy
Website
- Description: Provider of automatic carbon dioxide angiography solutions for hemodynamics, vascular surgery, and interventional radiology, including Angiodroid The CO2 Injector for peripheral diagnostic and interventional procedures, the Angiodroid Easy Kit disposable accessories, ANGIOPULSE counterpulsation weaning console, and the ACDA Academy offering training, articles, conferences, and live case streaming.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Angiodroid company profile →
Cardio Polymers
HQ: United States
Website
- Description: Provider of biocompatible polymer implant therapies and implantable devices to treat chronic heart failure, mitral valve regurgitation, and postoperative atrial fibrillation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardio Polymers company profile →
Atacor
HQ: United States
Website
- Description: Provider of extravascular cardiac lead systems enabling defibrillation, bradycardia pacing, and anti-tachycardia pacing without contacting the heart or vascular system, including the AtaCor EV-ICD Lead System and the EV Temporary Pacing Lead System that provides pacing support via a parasternal approach.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Atacor company profile →
Coherex Medical
HQ: United States
Website
- Description: Provider of medical devices addressing structural heart disease, including a patent foramen ovale (PFO) closure system designed to stimulate tissue in-growth for long-term closure, and the WaveCrest Left Atrial Appendage Occlusion System to close the left atrial appendage and reduce stroke risk in atrial fibrillation patients who cannot tolerate chronic oral anticoagulation therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Coherex Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Corvidia Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Corvidia Therapeutics
2.2 - Growth funds investing in similar companies to Corvidia Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Corvidia Therapeutics
4.2 - Public trading comparable groups for Corvidia Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →